Integration of the Molecular Classification of Endometrial Carcinoma to Select Patients for Fertility Sparing Strategies
Mohamed Amine Bani,Amandine Maulard,Philippe Morice,Cyrus Chargari,Catherine Genestie,MOHAMED AMINE BANI,AMANDINE MAULARD,PHILIPPE MORICE,CYRUS CHARGARI,CATHERINE GENESTIE
DOI: https://doi.org/10.21873/anticanres.16832
2024-02-01
Anticancer Research
Abstract:Fertility-sparing treatment (FST) for endometrial carcinoma (EC) is an option for a subgroup of young women with low-risk disease. The low-risk group comprises patients with endometrioid EC stage IA, grade 1, with or without focal lymphovascular invasion. In the era of molecular subtyping, treatment de-escalation for some EC subtypes is recommended. Recommendations for fertility-preserving treatments were developed regardless of the molecular classification of EC. However, few studies have focused on this topic. In this review, we summarize the actual data available in the literature and discuss the impact of some molecular subtypes of FST.
oncology
What problem does this paper attempt to address?